Search results
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via Yahoo News· 3 days agoAbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine...
Genetic changes identified as key to childhood lupus
Medical Xpress· 6 days agoIn people with lupus the body's immune system mistakenly attacks its own cells and tissues. Until now, its exact cause has been unknown, but it was thought to be a combination of genetic and ...
New drug in Duke-led clinical trial shows improvement in people with common autoimmune disease
WUNC Chapel Hill· 3 days agoA new drug has shown benefits in clinical trials for one of the most common autoimmune diseases. Sjögren’s disease affects an estimated 1 to 4 million people in the United States. “About a quarter ...
Scilex secures FDA nod for Gloperba gout treatment launch By Investing.com
Investing.com· 3 days agoScilex Holding Company (NASDAQ:SCLX) announced today that it has received FDA approval to commence...
Skater Puts Rare Condition on Ice: CRMO
WILX 10 Lansing· 3 days agoIf your child is in pain and you’re chalking it up to growing pains, think again. It may be because of a rare condition. Figure skating is hard enough....
AbbVie's tight grip on Humira market raises concerns about biosimilars By Reuters
Investing.com· 3 days agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew...
AbbVie's tight grip on Humira market raises concerns about biosimilars
AOL· 3 days agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew of biosimilars, which are close but not exact copies of branded biologic medicines. But after ...
